Chronic Granulomatous Disease: Report on a National Registry of 368 PatientsJerry A. Winkelstein, Howard B. Dickler, Steven J. Chanock et al.|Medicine|2000Cited by 1.7k
Andexanet Alfa for the Reversal of Factor Xa Inhibitor ActivityDeborah Siegal, Mark Crowther, Vandana Mathur et al.|New England Journal of Medicine|2015Cited by 1k
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J. Connolly, Truman J. Milling, Mark Crowther et al.|New England Journal of Medicine|2019Cited by 945